Andrew David Grotzinger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Andrew David Grotzinger has a total of 463 co-authors. Here are the top co-authors by number of shared publications:
- Elliot M. Tucker-Drob
Department of Psychology, The University of Texas at Austin
25 shared publications - Michel G. Nivard
University of Bristol
17 shared publications - Travis Triplett Mallard
Massachusetts General Hospital
17 shared publications - Kathryn Paige Harden
Department of Psychology, The University of Texas at Austin
15 shared publications Elliot M. Tucker-Drob
Department of Psychology, University of Texas at Austin, Austin, Texas; Population Research Center, University of Texas at Austin, Austin, Texas
7 shared publications- Javier de la Fuente
Department of Psychology, University of Texas at Austin
7 shared publications
Latest Publications
- Open Access
Sex and generation shape the genetic architecture of smoking initiation
The rapidly changing cultural contexts over the past century modified the genetic factors that influence smoking initiation (SI). Using data from nearly seven million respondents, we conducted genome-wide associations study (GWAS) meta-analyses stratified by sex and generation across European, East Asian, African American, and Latino genetic ancestry populations. Sex and generation, but not genetic ancestry, moderate both the SNP-based heritability estimates and associations with individual loci. Specifically, SI is more heritable in females and younger generations. Furthermore, the impact of both discrete policy changes that target smoking and the gradual cultural redefinition of smoking norms across sex and generation are captured within the patterns of cross-trait genetic correlations between SI and extant smoking-relevant phenotypes. Robust cross-ancestry genetic correlations allowed us to meta-analyze the results across subsamples, identifying 1,717 loci associated with SI, including both main and moderated associations for either moderator. Genome-wide heterogeneity analyses identified 45 sex-specific loci and 7 generation-specific loci with distinct associations with SI. Finemapping analyses highlighted 389 and 304 loci with distinct patterns of potential causal variants by sex and generation. Accordingly, sex- and generation-specific macrosocial contexts dynamically influence the genetic architecture of SI, underscoring the need to consider gene-environment interplay for health behaviors as societal norms evolve.
Open AccessSex and generation shape the genetic architecture of smoking initiation
The rapidly changing cultural contexts over the past century modified the genetic factors that influence smoking initiation (SI). Using data from nearly seven million respondents, we conducted genome-wide associations study (GWAS) meta-analyses stratified by sex and generation across European, East Asian, African American, and Latino genetic ancestry populations. Sex and generation, but not genetic ancestry, moderate both the SNP-based heritability estimates and associations with individual loci. Specifically, SI is more heritable in females and younger generations. Furthermore, the impact of both discrete policy changes that target smoking and the gradual cultural redefinition of smoking norms across sex and generation are captured within the patterns of cross-trait genetic correlations between SI and extant smoking-relevant phenotypes. Robust cross-ancestry genetic correlations allowed us to meta-analyze the results across subsamples, identifying 1,717 loci associated with SI, including both main and moderated associations for either moderator. Genome-wide heterogeneity analyses identified 45 sex-specific loci and 7 generation-specific loci with distinct associations with SI. Finemapping analyses highlighted 389 and 304 loci with distinct patterns of potential causal variants by sex and generation. Accordingly, sex- and generation-specific macrosocial contexts dynamically influence the genetic architecture of SI, underscoring the need to consider gene-environment interplay for health behaviors as societal norms evolve.
- Open Access
- 23 September 2026
- Published by Springer Nature in Behavior Genetics
- p. 1
Correction: Uncovering the Role of Biological Sex in the Divergent Genetic Profiles of Early and Late-Diagnosed Autism
- 23 September 2026
- Published by Springer Nature in Behavior Genetics
- p. 1
Open AccessCorrection: Uncovering the Role of Biological Sex in the Divergent Genetic Profiles of Early and Late-Diagnosed Autism
- Open Access
- 27 August 2026
- Published by Springer Nature in Behavior Genetics
- p. 1-13
Uncovering the Role of Biological Sex in the Divergent Genetic Profiles of Early and Late-Diagnosed Autism
Autism is a neurodevelopmental disorder with a significant male prevalence bias. While recent evidence suggests that genetic heterogeneity is indexed by age at diagnosis, males are also typically diagnosed earlier, such that the extent to which these age-specific findings are confounded by shared genetic signal with sex-specific genetic architecture remains unclear. To test this, we leveraged sex- and age of diagnosis-stratified GWAS summary statistics for autism and applied a multiple regression framework within Genomic Structural Equation Modeling (Genomic SEM). This approach allowed us to disentangle the overlapping genetic variance between sex, diagnostic timing, and 68 clinically relevant phenotypes reflecting a host of different psychiatric, cognitive, health, and social outcomes. Consistent with prior findings, we identified significantly divergent genetic associations with external traits between early- and late-diagnosed autism subtypes. We also identified few findings for sex-specific associations, along with high genetic correlations across these two traits, which questions the biological basis for disproportionate prevalence rates in males. Multiple regression models confirmed that early-specific associations were not confounded by biological sex. Conversely, the correlations between late-diagnosed autism and the sex-stratified autism GWAS were near 1, indicating that late-specific associations may be confounded. Follow-up analyses using an internalizing factor provided support for sex differences in clinical presentation and age at diagnosis, with female-diagnosed and late-diagnosed autism estimated to have stronger genetic correlations with internalizing traits compared to male and early-diagnosed counterparts. This study underscores the importance of subtyping in genetic analyses and provides a framework to disentangle confounded genetic pathways.
- 27 August 2026
- Published by Springer Nature in Behavior Genetics
- p. 1-13
Open AccessUncovering the Role of Biological Sex in the Divergent Genetic Profiles of Early and Late-Diagnosed Autism
Autism is a neurodevelopmental disorder with a significant male prevalence bias. While recent evidence suggests that genetic heterogeneity is indexed by age at diagnosis, males are also typically diagnosed earlier, such that the extent to which these age-specific findings are confounded by shared genetic signal with sex-specific genetic architecture remains unclear. To test this, we leveraged sex- and age of diagnosis-stratified GWAS summary statistics for autism and applied a multiple regression framework within Genomic Structural Equation Modeling (Genomic SEM). This approach allowed us to disentangle the overlapping genetic variance between sex, diagnostic timing, and 68 clinically relevant phenotypes reflecting a host of different psychiatric, cognitive, health, and social outcomes. Consistent with prior findings, we identified significantly divergent genetic associations with external traits between early- and late-diagnosed autism subtypes. We also identified few findings for sex-specific associations, along with high genetic correlations across these two traits, which questions the biological basis for disproportionate prevalence rates in males. Multiple regression models confirmed that early-specific associations were not confounded by biological sex. Conversely, the correlations between late-diagnosed autism and the sex-stratified autism GWAS were near 1, indicating that late-specific associations may be confounded. Follow-up analyses using an internalizing factor provided support for sex differences in clinical presentation and age at diagnosis, with female-diagnosed and late-diagnosed autism estimated to have stronger genetic correlations with internalizing traits compared to male and early-diagnosed counterparts. This study underscores the importance of subtyping in genetic analyses and provides a framework to disentangle confounded genetic pathways.
- Open Access
- 7 July 2026
- Published by Springer Nature in Molecular Psychiatry
- Vol. 31 (11) , 6422-6432
Molecular genetic influences on sustained attention and executive processes and their links with psychopathology in the AFFECT study
Both sustained attention (SA) and executive functioning (EF) are critical for adaptive behavior and compromised across a range of psychiatric disorders, yet their etiological relationships remain underexplored. Here, we report the first multivariate characterization of molecular genetic influences on SA (vigilance, lapse recovery cost, lapse propensity) and EF (processing speed, response selection, working memory). In collaboration with 23andMe, we report previously unpublished genome-wide association studies of these phenotypes in a single cohort of more than 20,000 individuals enriched for diagnoses of major depressive disorder and bipolar disorder. We used Genomic Structural Equation Modeling to formally model patterns of genetic covariance among these task-based measures of cognition, and their relationships with other cognitive, clinical, and imaging-derived phenotypes. We identified two distinct latent genetic factors: one influencing EF and one influencing SA. Both the EF and SA factors were genetically correlated with cognitive and clinical phenotypes, with each latent factor uniquely linked to liability for psychiatric disorders, including attention-deficit/hyperactivity disorder. However, genetic correlations with imaging-derived neuroanatomical phenotypes were modest and non-significant after correction for multiple comparisons. Collectively, these results provide an initial multivariate genetic characterization of SA and EF, though replication in larger and more diverse samples will be important. They suggest that genetic influences on sustained attention are generally distinct from those that influence executive function. The EF and SA factors show distinct patterns of genetic overlap with multiple cognitive and psychiatric outcomes, underscoring the need for more granular cognitive phenotyping to generate new insights into the genetic architecture of cognition and the etiology of psychopathology.
- 7 July 2026
- Published by Springer Nature in Molecular Psychiatry
- Vol. 31 (11) , 6422-6432
Open AccessMolecular genetic influences on sustained attention and executive processes and their links with psychopathology in the AFFECT study
Both sustained attention (SA) and executive functioning (EF) are critical for adaptive behavior and compromised across a range of psychiatric disorders, yet their etiological relationships remain underexplored. Here, we report the first multivariate characterization of molecular genetic influences on SA (vigilance, lapse recovery cost, lapse propensity) and EF (processing speed, response selection, working memory). In collaboration with 23andMe, we report previously unpublished genome-wide association studies of these phenotypes in a single cohort of more than 20,000 individuals enriched for diagnoses of major depressive disorder and bipolar disorder. We used Genomic Structural Equation Modeling to formally model patterns of genetic covariance among these task-based measures of cognition, and their relationships with other cognitive, clinical, and imaging-derived phenotypes. We identified two distinct latent genetic factors: one influencing EF and one influencing SA. Both the EF and SA factors were genetically correlated with cognitive and clinical phenotypes, with each latent factor uniquely linked to liability for psychiatric disorders, including attention-deficit/hyperactivity disorder. However, genetic correlations with imaging-derived neuroanatomical phenotypes were modest and non-significant after correction for multiple comparisons. Collectively, these results provide an initial multivariate genetic characterization of SA and EF, though replication in larger and more diverse samples will be important. They suggest that genetic influences on sustained attention are generally distinct from those that influence executive function. The EF and SA factors show distinct patterns of genetic overlap with multiple cognitive and psychiatric outcomes, underscoring the need for more granular cognitive phenotyping to generate new insights into the genetic architecture of cognition and the etiology of psychopathology.
- Open Access
Ultra-Fast Implementation of Multivariate GWAS in Genomic SEM Using Flexible Analytic Estimation
Many medical, physiological, and psychiatric traits and disorders are highly polygenic and exhibit complex patterns of genetic sharing and differentiation. In 2018, we introduced Genomic Structural Equation Modelling (Genomic SEM) as a formal framework and free, open source, R-based software for modelling the multivariate genetic architecture of both continuous and binary Genome-Wide Association Study (GWAS) phenotypes, interrogating their joint and distinct functional genomic pathways, and leveraging empirical models of the genetic relations among phenotypes to guide multivariate GWAS discovery. Here we introduce a closed-form analytic solution for estimating SNP effects within multivariate GWAS in Genomic SEM. This estimator is over 800 times faster than the existing iterative estimator, drastically decreasing reliance on high performance computing (HPC). On a MacBook pro laptop with M4 Max chip, a multivariate GWAS (∼1M SNPs) of 5 common factors underlying 13 phenotypes takes approximately 2 minutes. Concurrent with the release of this preprint, we are adding an analytic estimation option to the userGWAS function in the GenomicSEM package for alpha testing along with a tutorial on our GitHub wiki.
Open AccessUltra-Fast Implementation of Multivariate GWAS in Genomic SEM Using Flexible Analytic Estimation
Many medical, physiological, and psychiatric traits and disorders are highly polygenic and exhibit complex patterns of genetic sharing and differentiation. In 2018, we introduced Genomic Structural Equation Modelling (Genomic SEM) as a formal framework and free, open source, R-based software for modelling the multivariate genetic architecture of both continuous and binary Genome-Wide Association Study (GWAS) phenotypes, interrogating their joint and distinct functional genomic pathways, and leveraging empirical models of the genetic relations among phenotypes to guide multivariate GWAS discovery. Here we introduce a closed-form analytic solution for estimating SNP effects within multivariate GWAS in Genomic SEM. This estimator is over 800 times faster than the existing iterative estimator, drastically decreasing reliance on high performance computing (HPC). On a MacBook pro laptop with M4 Max chip, a multivariate GWAS (∼1M SNPs) of 5 common factors underlying 13 phenotypes takes approximately 2 minutes. Concurrent with the release of this preprint, we are adding an analytic estimation option to the userGWAS function in the GenomicSEM package for alpha testing along with a tutorial on our GitHub wiki.
- Open Access
- 21 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Shared Genetic Liability across Systems of Psychiatric and Physical Illness
Epidemiological literature describes widespread psychiatric–physical comorbidity. However, the extent to which observed bivariate risk is transdiagnostic remains uncertain. We apply Genomic SEM and introduce Genomic E-SEM, an exploratory factor-analytic extension of Genomic SEM, here applied to 73 physical outcomes (~1.9 million cases) across eight medical domains. We then modeled latent physical illness factors alongside previously identified psychiatric factors. Thought/psychotic and compulsive factors exhibited few associations with physical illness factors. Conversely, internalizing, neurodevelopmental, and substance-use factors showed substantial genome-wide genetic correlations with all physical illness systems. Multivariate GWAS of a transdiagnostic physical illness factor, defined by 21 physical disorders, identified 27 genomic risk loci and exhibited substantial predictive validity in subsequent PheWAS. This transdiagnostic factor again exhibited substantial genome-wide genetic correlations with internalizing, neurodevelopmental, and substance-use factors. Our results reveal pervasive risk sharing between specific groups of psychiatric and physical conditions and suggest the need for additional nosological frameworks.
- 21 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessShared Genetic Liability across Systems of Psychiatric and Physical Illness
Epidemiological literature describes widespread psychiatric–physical comorbidity. However, the extent to which observed bivariate risk is transdiagnostic remains uncertain. We apply Genomic SEM and introduce Genomic E-SEM, an exploratory factor-analytic extension of Genomic SEM, here applied to 73 physical outcomes (~1.9 million cases) across eight medical domains. We then modeled latent physical illness factors alongside previously identified psychiatric factors. Thought/psychotic and compulsive factors exhibited few associations with physical illness factors. Conversely, internalizing, neurodevelopmental, and substance-use factors showed substantial genome-wide genetic correlations with all physical illness systems. Multivariate GWAS of a transdiagnostic physical illness factor, defined by 21 physical disorders, identified 27 genomic risk loci and exhibited substantial predictive validity in subsequent PheWAS. This transdiagnostic factor again exhibited substantial genome-wide genetic correlations with internalizing, neurodevelopmental, and substance-use factors. Our results reveal pervasive risk sharing between specific groups of psychiatric and physical conditions and suggest the need for additional nosological frameworks.
- Top Cited PapersOpen Access
- 10 December 2025
- Published by Springer Nature in Nature
- Vol. 649 (8096) , 406-415
Mapping the genetic landscape across 14 psychiatric disorders
Psychiatric disorders display high levels of comorbidity and genetic overlap1,2, challenging current diagnostic boundaries. For disorders for which diagnostic separation has been most debated, such as schizophrenia and bipolar disorder3, genomic methods have revealed that the majority of genetic signal is shared4. While over a hundred pleiotropic loci have been identified by recent cross-disorder analyses5, the full scope of shared and disorder-specific genetic influences remains poorly defined. Here we addressed this gap by triangulating across a suite of cutting-edge statistical and functional genomic analyses applied to 14 childhood- and adult-onset psychiatric disorders (1,056,201 cases). Using genetic association data from common variants, we identified and characterized five underlying genomic factors that explained the majority of the genetic variance of the individual disorders (around 66% on average) and were associated with 238 pleiotropic loci. The two factors defined by (1) Schizophrenia and bipolar disorders (SB factor); and (2) major depression, PTSD and anxiety (Internalizing factor) showed high levels of polygenic overlap6 and local genetic correlation and very few disorder-specific loci. The genetic signal shared across all 14 disorders was enriched for broad biological processes (for example, transcriptional regulation), while more specific pathways were shared at the level of the individual factors. The shared genetic signal across the SB factor was substantially enriched in genes expressed in excitatory neurons, whereas the Internalizing factor was associated with oligodendrocyte biology. These observations may inform a more neurobiologically valid psychiatric nosology and implicate targets for therapeutic development designed to treat commonly occurring comorbid presentations.
- 10 December 2025
- Published by Springer Nature in Nature
- Vol. 649 (8096) , 406-415
Top Cited PapersOpen AccessMapping the genetic landscape across 14 psychiatric disorders
Psychiatric disorders display high levels of comorbidity and genetic overlap1,2, challenging current diagnostic boundaries. For disorders for which diagnostic separation has been most debated, such as schizophrenia and bipolar disorder3, genomic methods have revealed that the majority of genetic signal is shared4. While over a hundred pleiotropic loci have been identified by recent cross-disorder analyses5, the full scope of shared and disorder-specific genetic influences remains poorly defined. Here we addressed this gap by triangulating across a suite of cutting-edge statistical and functional genomic analyses applied to 14 childhood- and adult-onset psychiatric disorders (1,056,201 cases). Using genetic association data from common variants, we identified and characterized five underlying genomic factors that explained the majority of the genetic variance of the individual disorders (around 66% on average) and were associated with 238 pleiotropic loci. The two factors defined by (1) Schizophrenia and bipolar disorders (SB factor); and (2) major depression, PTSD and anxiety (Internalizing factor) showed high levels of polygenic overlap6 and local genetic correlation and very few disorder-specific loci. The genetic signal shared across all 14 disorders was enriched for broad biological processes (for example, transcriptional regulation), while more specific pathways were shared at the level of the individual factors. The shared genetic signal across the SB factor was substantially enriched in genes expressed in excitatory neurons, whereas the Internalizing factor was associated with oligodendrocyte biology. These observations may inform a more neurobiologically valid psychiatric nosology and implicate targets for therapeutic development designed to treat commonly occurring comorbid presentations.
- 11 November 2025
- Published by Springer Nature in Nature Neuroscience
- Vol. 28 (12) , 2439-2450
A genome-wide analysis of the shared genetic risk architecture of complex neurological and psychiatric disorders
Although neurological and psychiatric disorders have historically been considered to reflect distinct pathogenic entities, recent findings suggest shared pathophysiological mechanisms. However, the extent to which these heritable disorders share genetic influences remains unclear. Here we performed a comprehensive analysis of genome-wide association study data, involving nearly 1 million cases across ten neurological diseases and ten psychiatric disorders, to compare their common genetic signal and biological associations. Using complementary statistical tools, we demonstrate that a large set of common genetic variants impacts the risk of multiple neurological and psychiatric disorders, even in the absence of genetic correlations. Furthermore, genome-wide association studies on psychiatric disorders consistently implicate neuronal biology, whereas neurological diseases are associated with diverse neurobiological processes. Together, this study elucidates the genetic relationship between complex neurological and psychiatric disorders, indicating a larger degree of genetic pleiotropy than previously recognized. The findings have implications for disease classification, precision medicine and clinical practice.
- 11 November 2025
- Published by Springer Nature in Nature Neuroscience
- Vol. 28 (12) , 2439-2450
A genome-wide analysis of the shared genetic risk architecture of complex neurological and psychiatric disorders
Although neurological and psychiatric disorders have historically been considered to reflect distinct pathogenic entities, recent findings suggest shared pathophysiological mechanisms. However, the extent to which these heritable disorders share genetic influences remains unclear. Here we performed a comprehensive analysis of genome-wide association study data, involving nearly 1 million cases across ten neurological diseases and ten psychiatric disorders, to compare their common genetic signal and biological associations. Using complementary statistical tools, we demonstrate that a large set of common genetic variants impacts the risk of multiple neurological and psychiatric disorders, even in the absence of genetic correlations. Furthermore, genome-wide association studies on psychiatric disorders consistently implicate neuronal biology, whereas neurological diseases are associated with diverse neurobiological processes. Together, this study elucidates the genetic relationship between complex neurological and psychiatric disorders, indicating a larger degree of genetic pleiotropy than previously recognized. The findings have implications for disease classification, precision medicine and clinical practice.